tradingkey.logo

Protara Therapeutics Inc <TARA.OQ> expected to post a loss of 40 cents a share - Earnings Preview

ReutersAug 1, 2025 2:17 PM
  • Protara Therapeutics Inc TARA.OQ TARA.O is expected to show no change in quarterly revenue when it reports results on August 4 (estimated) for the period ending June 30 2025

  • ​LSEG's mean analyst estimate for Protara Therapeutics Inc is for a loss of 40 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Protara Therapeutics Inc is $22.50, about 86.2% above its last closing price of $3.10

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Mar. 31 2025

-0.40

-0.45

-0.29

Beat

35.8

Dec. 31 2025

-0.56

-0.56

-0.49

Beat

13.3

Sep. 30 2024

-0.52

-0.52

-0.50

Beat

3.8​

Jun. 30 2024

-0.96

-0.80

-0.45

Beat

43.8

​​Mar. 31 2024

-0.86

-0.92

-0.97

Missed

-5.4

Dec. 31 2023

-0.92

-0.90

Beat

1.9​

Sep. 30 2023

-1.04

-0.98

-0.87

Beat

11.2

Jun. 30 2023

-0.88

-0.87

-1.00

Missed

-14.3

This summary was machine generated August 1 at 14:17 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI